Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma

NCT00967044 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Panobinostat
DRUG: Everolimus

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]